Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Shares Plummet 35 Percent on Widened Loss

NEW YORK, June 22 (GenomeWeb News) - Shares of Orchid Cellmark dropped $1.30, or 35.1 percent, to $2.40 in afternoon trading after the company said its first-quarter revenues declined 14 percent and losses increased.


As reported today in GenomeWeb News, Orchid's revenues declined to $12.6 million in the first quarter of 2006, from $14.7 million during the first quarter of 2005. Losses increased to $6.6 million from $1.7 million in the year-ago period. 

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.